CAS 1286279-29-5

BMS-813160

CAS: 1286279-29-5

BMS-813160

Reinheit: ≥98%

Molekulargewicht: 484.64g/mol

Ref: 54-BUP08645

BMS-813160

CAS: 1286279-29-5

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.

Formel: C₂₅H₄₀N₈O₂

Reinheit: 99.66% - 99.79%

Farbe und Form: Solid

Molekulargewicht: 484.64

Ref: TM-T4584

BMS 813160

CAS: 1286279-29-5

Antagonist of chemokine receptors CCR2 and CCR5

Formel: C₂₅H₄₀N₈O₂

Reinheit: Min. 95%

Molekulargewicht: 484.64 g/mol

Ref: 3D-BB164193